Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

celltrion1

Celltrion’s Herceptin biosimilar seals EU approval

February 15, 2018 Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma

Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …
News
jj

J&J’s apalutamide scores snap FDA approval in castration-resistant prostate cancer subgroup

February 15, 2018 Sales and Marketing Cancer, Erleada, FDA, J&J, JJ, Johsnon & Johnson, apalutamide, pharma, prostate cancer

Johnson & Johnson has announced that its androgen receptor inhibitor apalutamide, now branded as Erleada, has received approval from the …
News

Astellas scoops up Universal Cells for $102.5m

February 15, 2018 Sales and Marketing Astellas, Universal Cells, biotech, drugs, pharma, pharmaceutical

Astellas Pharma had only signed an exclusive licensing deal with Universal Cells back in October for the co-development of a …
News

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
News
shutterstock_273326141

Roivant signs $600m licensing deal with Poxel

February 13, 2018 Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma

Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …
News
cell-3089947_960_720

Vertex gets approval for combo-therapy in cystic fibrosis

February 13, 2018 Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …
News
pills-384846_960_720

Purdue pulls plug on opioid marketing

February 13, 2018 Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …
News
network-1989146_960_720

Taking a look behind the scenes of Serialisation

February 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
Feature

NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma

February 12, 2018 Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma

Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …
News

Sanofi in $155m influenza vaccine deal

February 12, 2018 Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical

Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
News

Novo’s Ozempic secures European approval in type 2 diabetes

February 12, 2018 Sales and Marketing EC, EMA, Europe, Novo Nordisk, diabetes, pharma

Novo Nordisk has revealed that its drug Ozempic (semaglutide) has received approval from the European Commission (EC) as a monotherapy …
News

Trump’s drug pricing reforms lack bite

February 12, 2018 Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
News
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018 Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
News
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026